As of 12:11:41 PM EST. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
125,844.00
182,237.00
247,056.00
271,157.00
Total Liabilities Net Minority Interest
68,759.00
23,458.00
19,534.00
22,156.00
Total Equity Gross Minority Interest
57,085.00
158,779.00
227,522.00
249,001.00
Total Capitalization
57,085.00
158,779.00
227,522.00
249,001.00
Common Stock Equity
57,085.00
158,779.00
227,522.00
249,001.00
Capital Lease Obligations
6,088.00
1,918.00
3,673.00
5,275.00
Net Tangible Assets
57,085.00
158,779.00
227,522.00
249,001.00
Working Capital
90,566.00
145,452.00
155,674.00
176,582.00
Invested Capital
57,085.00
158,779.00
227,522.00
249,001.00
Tangible Book Value
57,085.00
158,779.00
227,522.00
249,001.00
Total Debt
6,088.00
1,918.00
3,673.00
5,275.00
Share Issued
54,480.70
53,797.34
53,480.81
49,872.21
Ordinary Shares Number
54,480.70
53,797.34
53,480.81
49,872.21
12/31/2020 - 1/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COEP Coeptis Therapeutics Holdings, Inc.
5.30
-3.67%
MRNS Marinus Pharmaceuticals, Inc.
0.5304
-0.88%
VSTM Verastem, Inc.
6.36
+23.02%
REVB Revelation Biosciences, Inc.
0.6641
+43.58%
FGEN FibroGen, Inc.
0.5277
-0.33%
RAPT RAPT Therapeutics, Inc.
1.7500
+10.76%
VINC Vincerx Pharma, Inc.
0.2421
-7.88%
KPTI Karyopharm Therapeutics Inc.
0.7640
+12.85%
NLSP NLS Pharmaceutics AG
2.2900
+8.53%
SPRC SciSparc Ltd.
0.3785
+5.14%